4th Soft Skills Workshop: Leadership and Career Guidance Across Academia and Business
Date and time: 13th November 2025 from 1:30 PM to 3:30 PM
Format: online
Language: English
Speaker: Pavol Čekan, PhD., Founder & CEO, MultiplexDX
Success in both academia and business depends on more than technical expertise - it requires strong leadership and strategic career planning. Yet, the pathways and challenges in these two worlds often differ: while academia emphasizes long-term research impact, teaching, and grant funding, business demands agility, stakeholder management, and measurable results. This interactive workshop will highlight the similarities and differences between leadership and career development in academia and business, helping participants recognize how skills can transfer across both sectors and how to navigate transitions between them.
Who Should Attend?
- Early-career and mid-career researchers
- PhD students and postdocs
- Academics looking to enhance leadership and career planning skills
- Professionals in R&D and business interested in cross-sector perspectives
Key Takeaways:
- Leadership Across Contexts – Explore how leadership is exercised in academic research groups versus business organizations, and how to adapt your style accordingly.
- Career Pathways – Compare academic and industry career trajectories, expectations, and evaluation systems.
- Transferable Skills – Identify soft skills that are valuable in both sectors and learn how to present them effectively.
- Navigating Transitions – Gain strategies for moving between academia and business and leveraging your experience in one to succeed in the other.
We look forward to your participation!
The Soft Skills program is part of the ADDIT-CE project. The Czech-Slovak consortium and center of excellence aims to develop, validate, and implement modern and innovative diagnostics for Alzheimer's disease.
This event has received funding from the European Union’s Horizon Europe program under Grant Agreement No. 101087124. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
If you have any questions: events@multiplexdx.com
About MultiplexDX
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.
Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter
